Hailey 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)
Hailey 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Hailey 1.5/30; Generic name: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL; Drug class: Estrogen [EPC].
| Brand name | Hailey 1.5/30 |
|---|---|
| Generic name | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL |
| Drug class | Estrogen [EPC] |
| Manufacturer | Glenmark Pharmaceuticals Inc., USA |
| Used for | INDICATIONS AND USAGE Hailey 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. TABLE 1 LOWEST EXPECTED AND TYPICAL FAILURE RATES DURING THE FIRST YEAR OF CONTINUOUS USE OF A METHOD % Of Women Experiencing an Unintended Pregnancy in the First Year of C |
| Dosage | DOSAGE AND ADMINISTRATION The tablet dispenser has been designed to make oral contraceptive dosing as easy and as convenient as possible. The tablets are arranged in three rows of seven tablets each, with the days of the week appearing on the tablet dispenser above the first row of tablets. Note: Each tablet dispenser has been preprinted with the days of the week, starting with Sunday, to facilitate a Sunday-Start regimen. Six different day label strips have been provided with the Detailed Patie |
| Warnings | WARNINGS The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence of other underlying risk factors such as hypertension, hyperlipidemias, obesity, and diabetes. Practi |
| Active ingredient(s) | ETHINYL ESTRADIOL |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=021df70a-0c37-4237-a2f7-2597ff6d41f5 |